Smallpox — Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years
Citation(s)
An Open-label Controlled Study of the Safety and Tolerability of the Live Cell-based Vaccine Against Smallpox and Other Orthopoxvirus Infections (VAC∆6 Vaccine) Based on Vaccinia Virus, in Volunteers Aged 18-40 Years